Related Experiment Video
Updated: Jul 9, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study
M B Bista1, M K Banerjee, S H Shin
1Epidemiology and Disease Control Division, Ministry of Health, Kathmandu, Nepal.
Insights
A single dose of the SA 14-14-2 Japanese encephalitis (JE) vaccine demonstrated 99.3% efficacy in preventing JE in children. This confirms that one dose is highly effective, even when administered shortly before potential exposure to the virus.
Area of Science:
- Vaccinology
- Epidemiology
- Public Health
Background:
- The SA 14-14-2 live-attenuated Japanese encephalitis (JE) vaccine has been administered to 120 million children in China since 1989.
- Previous studies indicated high efficacy for two doses (98%) and suggested high efficacy for a single dose.
Purpose of the Study:
- To confirm the high efficacy of a single dose of the SA 14-14-2 live-attenuated JE vaccine.
- To evaluate the effectiveness of the JE vaccine in a real-world setting in Nepal.
Main Methods:
- A matched case-control study was conducted in Nepal between July and August 1999.
- 160,000 children aged 1-15 years received the JE vaccine.
- Cases of JE were identified through hospital records, and vaccination status was compared to age-sex matched village controls.
Main Results:
- 20 children with confirmed JE were identified in vaccine-receiving villages.
- None of the JE cases had received the vaccine.
- Vaccination coverage among controls was 326 out of 557.
- The efficacy of a single JE vaccine dose was calculated at 99.3% (CI 94.9-100%).
Conclusions:
- A single dose of the SA 14-14-2 JE vaccine is highly efficacious.
- The vaccine provides significant protection against Japanese encephalitis, even when given shortly before infection exposure.
Background:
In China, since 1989, an estimated 120 million children have been immunised with the SA 14-14-2 live-attenuated Japanese encephalitis (JE) vaccine at ages 1, 2, and 6 years. A case-control study of licensed vaccine found two doses to be 98% effective. Subsequently, researchers found that single-dose vaccine efficacy was high; we aimed to confirm this result.
Methods:
During July 11-24, 1999, 160000 doses of JE vaccine were given to children aged 1-15 years, resident in three districts of Nepal. Several cases of JE were admitted to hospital from early August. We obtained names and addresses of cases with serological evidence of a recent infection from Bheri Zonal Hospital, Nepalgunj. We did a matched case-control study and calculated the odds ratio of vaccination among JE cases and age-sex matched village controls.
Findings:
20 children, aged 1-15 years, were identified whose illness conformed with the JE case definition and were resident in villages receiving the vaccine. None of 20 JE cases had received JE vaccine compared with 326 of 557 age-sex matched village controls. The efficacy of a single dose of JE vaccine was 99.3% (CI 94.9-100%).
Interpretation:
A single dose of JE vaccine is highly efficacious in preventing Japanese encephalitis when administered only days or weeks before exposure to infection.
More Related Videos
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
08:36The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Related Concept Videos
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Pharmaceutical Poisoning: Treatment Strategies
Arboviral Encephalitis
Encephalitis l: Introduction